KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Diebold Nixdorf (DBD) EBITDA (2016 - 2025)

Diebold Nixdorf's EBITDA history spans 17 years, with the latest figure at $82.4 million for Q4 2025.

  • For Q4 2025, EBITDA rose 100.0% year-over-year to $82.4 million; the TTM value through Dec 2025 reached $242.0 million, up 32.89%, while the annual FY2025 figure was $242.0 million, 32.89% up from the prior year.
  • EBITDA reached $82.4 million in Q4 2025 per DBD's latest filing, up from $73.8 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $82.4 million in Q4 2025 to a low of -$91.5 million in Q2 2022.
  • Average EBITDA over 5 years is $20.0 million, with a median of $36.2 million recorded in 2021.
  • Peak YoY movement for EBITDA: tumbled 809.3% in 2022, then surged 1912.82% in 2024.
  • A 5-year view of EBITDA shows it stood at $49.3 million in 2021, then plummeted by 185.8% to -$42.3 million in 2022, then surged by 187.23% to $36.9 million in 2023, then grew by 11.65% to $41.2 million in 2024, then skyrocketed by 100.0% to $82.4 million in 2025.
  • Per Business Quant, the three most recent readings for DBD's EBITDA are $82.4 million (Q4 2025), $73.8 million (Q3 2025), and $56.2 million (Q2 2025).